Literature DB >> 28959101

Evaluation of Daily Blood Pressure Alteration in Subclinical Hypothyroidism.

Ismail Polat Canbolat1, Erdal Belen2, Akif Bayyigit3, Aysen Helvaci4, Kadriye Kilickesmez5.   

Abstract

BACKGROUND: Subclinical hypothyroidism is the most common thyroid dysfunction in the general population. The relationship between overt thyroid dysfunction and hypertension is generally understood. Besides high blood pressure, non-dipper hypertension is known to increase cardiovascular risk. Our aim is to investigate daily blood pressure changes and the frequency of non-dipping patterns in patients with subclinical hypothyroidism.
METHODS: Forty-nine patients without hypertension with subclinical hypothyroidism were compared with 50 healthy sex- and age-matched controls using ambulatory blood pressure monitoring.
RESULTS: Thyroid-stimulating hormone (TSH) levels were significantly higher in the subclinic hypothyroidism group, and there was no difference between free triiodothyronine (FT3) and free thyroxine (FT4) levels which could be predicted as a result of the study design. Levels of mean diastolic, daytime diastolic, nighttime diastolic and nighttime systolic blood pressure were significantly higher in the subclinic hypothyroidism group (p = 0.001 for mean, daytime and nighttime diastolic and p = 0.01 for nighttime systolic). Diastolic non-dipping occurred more frequently in the subclinic hypothyroidism group [subclinical hypothyroidism group 24 patients (49%), control group 13 patients (26%), p = 0.01]. On multivariate analysis, subclinical hypothyroidism was independently associated with diastolic non-dipping (95% confidence interval 1.162-8.053, odds ratio 1.182, p = 0.024).
CONCLUSIONS: Our study found that both the frequency of diastolic non-dipping pattern and diastolic blood pressure increase with subclinical hypothyroidism. Therfore, it would appear that searching for non-dipping pattern can add valuable information for patients with subclinical hypothyroidism.

Entities:  

Keywords:  Cardiovascular risk; Hypertension; Nondipping; Subclinical hypothyroidism

Year:  2017        PMID: 28959101      PMCID: PMC5611345          DOI: 10.6515/acs20170220b

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  28 in total

Review 1.  Prognostic value of ambulatory blood pressure : current evidence and clinical implications.

Authors:  P Verdecchia
Journal:  Hypertension       Date:  2000-03       Impact factor: 10.190

Review 2.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

3.  The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries.

Authors:  K W Park; H B Dai; K Ojamaa; E Lowenstein; I Klein; F W Sellke
Journal:  Anesth Analg       Date:  1997-10       Impact factor: 5.108

Review 4.  Night-time blood pressure patterns and target organ damage: a review.

Authors:  Faye S Routledge; Judith A McFetridge-Durdle; C R Dean
Journal:  Can J Cardiol       Date:  2007-02       Impact factor: 5.223

5.  The effect of overt and subclinical hypothyroidism on the development of non-dipper blood pressure.

Authors:  Salih Inal; Mehmet A Karakoç; Erdal Kan; Fatma A Ebinç; Füsun B Törüner; Metin Aslan
Journal:  Endokrynol Pol       Date:  2012       Impact factor: 1.582

6.  [Ambulatory blood pressure monitoring in normotensive patients with subclinical hypothyroidism].

Authors:  Marcia Martins Ferreira; Patricia de Fatima dos Santos Teixeira; Vera Aleta R Mansur; Vaneska Spinelli Reuters; Cloyra Paiva Almeida; Mario Vaisman
Journal:  Arq Bras Cardiol       Date:  2010-04-30       Impact factor: 2.000

7.  Subclinical hypothyroidism and the risk of coronary heart disease and mortality.

Authors:  Nicolas Rodondi; Wendy P J den Elzen; Douglas C Bauer; Anne R Cappola; Salman Razvi; John P Walsh; Bjørn O Asvold; Giorgio Iervasi; Misa Imaizumi; Tinh-Hai Collet; Alexandra Bremner; Patrick Maisonneuve; José A Sgarbi; Kay-Tee Khaw; Mark P J Vanderpump; Anne B Newman; Jacques Cornuz; Jayne A Franklyn; Rudi G J Westendorp; Eric Vittinghoff; Jacobijn Gussekloo
Journal:  JAMA       Date:  2010-09-22       Impact factor: 56.272

8.  Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation.

Authors:  G Mancia; A Zanchetti; E Agabiti-Rosei; G Benemio; R De Cesaris; R Fogari; A Pessina; C Porcellati; A Rappelli; A Salvetti; B Trimarco; E Agebiti-Rosei; A Pessino
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

9.  Acute effects of thyroid hormone on vascular smooth muscle.

Authors:  K Ojamaa; J D Klemperer; I Klein
Journal:  Thyroid       Date:  1996-10       Impact factor: 6.568

10.  Prognostic value of ambulatory blood pressure measurements: further analyses.

Authors:  D Perloff; M Sokolow; R M Cowan; R P Juster
Journal:  J Hypertens Suppl       Date:  1989-05
View more
  4 in total

1.  Our Stance towards the 2017 ACC/AHA High Blood Pressure Clinical Practice Guideline: Has the Pendulum Swung Too Far?

Authors:  Tzung-Dau Wang
Journal:  Acta Cardiol Sin       Date:  2018-01       Impact factor: 2.672

2.  Nocturnal Non-Dipping: An Overlooked Clinical Manifestation of Subclinical Hypothyroidism Linking to Increased Cardiovascular Risk.

Authors:  Hung-Ju Lin; Tzung-Dau Wang
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

Review 3.  Subclinical thyroid dysfunction and major depressive disorder.

Authors:  Grigorios N Karakatsoulis; Eva-Maria Tsapakis; Calypso Mitkani; Konstantinos N Fountoulakis
Journal:  Hormones (Athens)       Date:  2021-08-24       Impact factor: 2.885

4.  Blood pressure characteristics of subclinical hypothyroidism: an observation study combined with office blood pressure and 24-h ambulatory blood pressure.

Authors:  Peng Cai; Yan Peng; YuXi Chen; Yan Wang; Xukai Wang
Journal:  J Hypertens       Date:  2021-03-01       Impact factor: 4.776

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.